联康生物科技集团有限公司(股票代码:00690)在2026年4月8日发布截至2026年3月31日的股份变动月报表。报告显示,公司本月内未有新增发行、库藏或注销股份活动,已发行普通股数依旧维持在5,971,228,147股,库存股份数为0股。
根据公告,公司法定股本保持在500,000,000,000股,每股面值港币0.01元,总额为港币50亿。期权方面,多个先前授予的期权累计数量合计仍保持不变,报告期间未有期权行使或失效记录。
公司强调,截至本月底已符合相关公众持股量要求,并确认遵守香港联交所《上市规则》及其他适用法律法规规定。公告由公司秘书何咏欣女士签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.